000 01226nam a2200349 a 4500
005 20250913120910.0
008 981208s1985 xxk 00 eng b
010 _a85-25530
020 _a0443035555
035 _a102488
039 9 _y08-18-1999
_zload
090 _aWM171.D794 1984 9HUKM
090 _aWM171
245 1 0 _aDrug treatment of neurotic disorders
_bfocus on alprazolam
_bproceedings of an international symposium Vienna, Austria, 14-15 November 1984
_cEdited by Malcolm H. Lader, Huw C. Davies
260 _aEdinburgh
_bChurchill Livingstone
_c1985
300 _a186 p. : ill. ; 24 cm.
590 _a1
650 _aAnxiety Disorders
_xDrug therapy
_xCongresses
650 _aBenzodiazepine Tranquilizers
_xTherapeutic use
_xCongresses
650 _aBenzodiazepine
_xPharmacodynamics
_xCongresses
650 _aDepression
_xDrug therapy
_xCongresses
650 _aFear
_xCongresses
700 1 _aLader, Malcolm H.
700 1 _aDavies, Huw C.
907 _a.b10592155
_b2021-05-28
_c2019-11-12
942 _c01
_n0
_kWM171.D794 1984 9HUKM
914 _avtls000061564
991 _aFakulti Perubatan
998 _ah
_b1999-05-08
_cm
_da
_feng
_gxxk
_y0
_z.b10592155
999 _c61131
_d61131